TY - JOUR
T1 - The role of α4 and LFA-1 integrins in selectin-independent monocyte and neutrophil migration to joints of rats with adjuvant arthritis
AU - Birner, Ulrieke
AU - Issekutz, Thomas B.
AU - Walter, Ulrike
AU - Issekutz, Andrew C.
PY - 2000
Y1 - 2000
N2 - Monocytes and neutrophils are chronically recruited to joints in rheumatoid arthritis. In the joints of rats with adjuvant arthritis, this is mediated, in part, by selectin-dependent and selectin-independent mechanisms. To define the selectin-independent mechanisms, 51Cr-labeled blood monocytes, 111In-labeled neutrophils and function blocking mAb to the selectins and integrins were utilized. Integrins contributed to the selectin-independent monocyte migration to arthritic joints with 58-70% inhibition of this recruitment by anti-α4 or anti-LFA-1 mAb, relative to selectin blockade alone. α4 plus P-selectin blockade was as effective as combined blockade of α4, P-, E- and L-selectin, mediating ~ 83% of the overall monocyte migration to the joints. In contrast, LFA-1 was the predominant selectin-independent mechanism for neutrophil recruitment to the joints. LFA-1 together with P-selectin had essential roles in the talar joint. In dermal inflammation in the arthritic rats, LFA-1 accounted for most (69%) of the selectin-independent monocyte migration to the chemoattractant C5a(desArg) (zymosan-activated serum), whereas LFA-1 and Mac-1 both contributed to selectin-independent neutrophil recruitment to C5a(desArg). α4 integrin and P-selectin in concert mediated monocyte recruitment to lipopolysaccharide and IFN-γ lesions (81%). Thus: (1) either α4 or LFA-1 can mediate monocyte migration to arthritic joints in the absence of selectin function and α4 together with P-selectin is particularly important; (2) LFA-1 is the predominant mechanism of selectin-independent migration of neutrophils to inflamed joints; and (3) in arthritic rats, selectin-independent migration of monocytes and neutrophils to dermal inflammation is mediated by α4 or LFA-1 or both LFA-1 and Mac-1, depending on the leukocyte type, and inflammatory stimulus.
AB - Monocytes and neutrophils are chronically recruited to joints in rheumatoid arthritis. In the joints of rats with adjuvant arthritis, this is mediated, in part, by selectin-dependent and selectin-independent mechanisms. To define the selectin-independent mechanisms, 51Cr-labeled blood monocytes, 111In-labeled neutrophils and function blocking mAb to the selectins and integrins were utilized. Integrins contributed to the selectin-independent monocyte migration to arthritic joints with 58-70% inhibition of this recruitment by anti-α4 or anti-LFA-1 mAb, relative to selectin blockade alone. α4 plus P-selectin blockade was as effective as combined blockade of α4, P-, E- and L-selectin, mediating ~ 83% of the overall monocyte migration to the joints. In contrast, LFA-1 was the predominant selectin-independent mechanism for neutrophil recruitment to the joints. LFA-1 together with P-selectin had essential roles in the talar joint. In dermal inflammation in the arthritic rats, LFA-1 accounted for most (69%) of the selectin-independent monocyte migration to the chemoattractant C5a(desArg) (zymosan-activated serum), whereas LFA-1 and Mac-1 both contributed to selectin-independent neutrophil recruitment to C5a(desArg). α4 integrin and P-selectin in concert mediated monocyte recruitment to lipopolysaccharide and IFN-γ lesions (81%). Thus: (1) either α4 or LFA-1 can mediate monocyte migration to arthritic joints in the absence of selectin function and α4 together with P-selectin is particularly important; (2) LFA-1 is the predominant mechanism of selectin-independent migration of neutrophils to inflamed joints; and (3) in arthritic rats, selectin-independent migration of monocytes and neutrophils to dermal inflammation is mediated by α4 or LFA-1 or both LFA-1 and Mac-1, depending on the leukocyte type, and inflammatory stimulus.
UR - http://www.scopus.com/inward/record.url?scp=0033952625&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0033952625&partnerID=8YFLogxK
U2 - 10.1093/intimm/12.2.141
DO - 10.1093/intimm/12.2.141
M3 - Article
C2 - 10653849
AN - SCOPUS:0033952625
SN - 0953-8178
VL - 12
SP - 141
EP - 150
JO - International Immunology
JF - International Immunology
IS - 2
ER -